New study on malaria treatment in CHT

Chloroquine has lost it's effectiveness in treatment. The study under RBM combines three medicines -- Chloroquine, Pyrimethamine and Sulfadoxin, says doctor Samar Kumar Barua, civil surgeon of Rangamati.

The study has been stared first in Kaptai upazila and it will cover the three hill districts. It will continue one year. Malaria patients will be treating during the study, he said.

Tap here to add The Daily Star as a trusted source

Experts working under the RBM programme earlier conducted a research on 100 malaria patients in two upazilas in Khagrachhori and Bandarban.

Deadly Malaria claims hundreds of lives every year in the malaria prone-CHT region.

In Africa, anti-malarial tablet 'Maploquine' is much effective, but it is not commonly available in Bangladesh, he said.

"Each tablet costs TK 90. This is costly for CHT people", Samar said.

Assistant Professor of Chittagong Medical College Hospital Dr Redwan is conducting the research.